Le Lézard
Classified in: Health, Science and technology
Subjects: TDS, FVT

ExL Events Just Announced: The 7th CROWN to Be Held January 23-25, 2018 at the Westin Philadelphia


NEW YORK, July 27, 2017 /PRNewswire/ -- The 7th Annual CROWN Congress will be held on January 23?25, 2018 at the Westin Philadelphia, ExL Events recently announced.   This intimate summit attracts leading experts, forward-thinking visionaries, and senior-level executives and offers an interactive forum to discuss the forces changing the industry and how clinical operations must adapt to succeed. With well over half of the audience representing pharmaceutical, biotechnology and medical device companies and an even split between those focused on clinical operations, outsourcing, and quality, it's the perfect balance of perspectives making for engaging and productive discussions. 

With changing regulations driving new risk management strategies, patient centricity changing how trials are designed and developed, new technologies advancing data collection and interpretation, and industry consolidation making an impact on outsourcing strategies, clinical operations must change. So be part of the discussion that lays the groundwork for how, at next year's CROWN Congress.  

"We have many exciting new features planned for the 2018 CROWN Congress, including a track dedicated to issues specific to small and mid-sized companies, a focus on the changing outsourcing paradigm, a day dedicated to optimizing CNS clinical trials, and the impact of ICH E6 R2," says Event Director, Kristen Hunter of ExL Events. 

Expert speakers facilitate educational sessions, case studies, interactive panel discussions and workshops over the course of the three days. An exclusive exhibit area highlights leading clinical service providers ensuring you leave with the necessary connections to optimize your clinical operations. Start the New Year armed with knowledge on how the industry is evolving and what actions need to be taken to position your clinical operations for success in 2018 and beyond.

For more information and to register, visit www.crownclinical.com and don't miss the new discounted registration pricing options for pharma, biotech and device companies.

Get Involved:

 

SOURCE ExL Events


These press releases may also interest you

at 10:45
The "PCR Markets. Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets and by Application, Product and Place. With Executive and Consultant Guides, Including Customized Forecasting and Analysis. 2023 to 2027" report has been added to...

at 10:30
The "Licensing Deals in Biotechnology 2019-2024" report has been added to ResearchAndMarkets.com's offering. Licensing Deals in Biotechnology provides a detailed understanding and analysis of how and why companies enter licensing deals. Fully...

at 10:30
The "Molecular Diagnostics for Cancer: Markets Forecasts by Cancer Type, Product, and Place with Executive & Consultant Guides and Customization. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering. Exciting technical...

at 10:30
Closed System Transfer Devices Market in terms of revenue was estimated to be worth $1.1 billion in 2024 and is poised to reach $2.5 billion by 2029, growing at a CAGR of 14.5% from 2024 to 2029 according to a new report by MarketsandMarketstm. The...

at 10:30
RIVANNA®, a developer of imaging-based medical solutions, names Craig Loomis as senior director of product management. With over 25 years of extensive experience in global product development and commercialization within the healthcare sector, Mr....

at 10:10
The group division of Ameritas proudly announces its 17th consecutive certification as a BenchmarkPortal Center of Excellence, solidifying its position as a leader in customer service and support excellence. This prestigious recognition for 2023...



News published on and distributed by: